Sign in
PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results
John A. Wells, MD, FACS
Updates from the Field
2025
Protocol T Extension Results
2019
Becoming a Clinical Trialist
Nancy M. Holekamp, MD, FASRS
2022
Category: Pharmacology